Published in Cancer Weekly, September 25th, 2001
"Recently, mast cell tryptase has been identified as another potent proangiogenic factor in tumors, along with fibroblast and vascular endothelial growth factors," said L. Benitez-Bribiesca and coworkers, National Medical Center S-XXI, Mexico.
Members of the Oncology Research Unit at the medical center compared biopsy specimens of 63 patients diagnosed with dysplasia or cancer and 21 healthy controls for differences in mast cell tryptase expression in order to assess...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.